Clifford Brass

Clifford Brass has a diverse and extensive work experience in the pharmaceutical industry. Clifford is currently the Chief Medical Officer at Resolution Therapeutics since January 2023. Prior to that, they founded Brass Pharma Consulting LLC in September 2022, where they provided consultation to the pharmaceutical industry in various aspects of drug development. Before establishing their consulting firm, they held several leadership positions at Novartis, including Vice President and Head of Clinical Sciences in Hepatology, Gastroenterology, and Transplantation, as well as Vice President and Therapy Area Head in Hepatology and Transplantation. Clifford also served as the Executive Director of Clinical Research at Novartis from October 2011 to May 2017.

Earlier in their career, Clifford worked at Merck as an Executive Director of Clinical Research and a Director of Clinical Initiatives/Medical Affairs. During this time, they supported medical affairs in Hepatology and HIV, oversaw a network of medical liaisons and clinical support nurses, and managed various patient access programs.

Clifford Brass started their career at the University of Pennsylvania School of Medicine as an Assistant Professor of Medicine and Biochemistry & Biophysics. Additionally, they worked as a Medical Consultant at Brigham and Women's Hospital, affiliated with Harvard Medical School.

Overall, Clifford Brass's work experience showcases their expertise in drug development, clinical research, medical affairs, and academia.

Clifford Brass completed their undergraduate education at Harvard University, obtaining a Bachelor of Arts degree in Biochemical Sciences. Clifford then pursued medical training at The University of Chicago Pritzker School of Medicine, but no specific degree was mentioned. Following this, Clifford pursued further specialization in their field by completing a fellowship in Gastroenterology/Hepatology at Harvard University Medical School. Lastly, they attended Mount Sinai School of Medicine where they earned both an MD and a PhD degree in Medicine and Pharmacology, respectively.